Target intelligence / Profile preview

Salmonella species

Molecular classification
Other (Bacterium; Gram-negative rod; Enterobacteriaceae family)
01

Overview

Salmonella species is the name of a genus of rod-shaped, Gram-negative bacteria belonging to the family Enterobacteriaceae. This genus includes two main species, Salmonella enterica and Salmonella bongori; S. enterica alone encompasses thousands of serotypes, some of which are major human pathogens. Salmonella species are primarily intracellular pathogens and are distinguished by possessing O (somatic), H (flagellar), and in certain strains, Vi (capsular) antigens. These bacteria are motile, facultatively anaerobic, and capable of surviving in harsh environments. Salmonella infection is a leading cause of foodborne illness worldwide, resulting in diseases ranging from self-limited gastroenteritis to life-threatening systemic infections such as typhoid fever. As a therapeutic target, "Salmonella species" is too broad and not typically considered a direct drug target. Instead, drug discovery efforts focus on essential bacterial enzymes and proteins. The genus is an important focus of antimicrobial therapy, public health surveillance, and vaccine development, with major challenges arising from its antigenic variability, ability to form biofilms, and capacity for rapid acquisition of antibiotic resistance genes[1][3][5][7][8].

Other names
SalmonellaSalmonellaeSalmonella spp.Salmonella entericaSalmonella bongori
02

Mechanism of action

Inhibition of bacterial protein synthesis or cell wall synthesis by antibiotics - Inhibition of specific bacterial biosynthetic enzymes/proteins (experimental)[2][4]

03

Biological functions

Pathogenesis (Infection)Intracellular survivalImmune system evasionBiofilm formation
04

Disease associations

Infection (e.g., salmonellosis, typhoid fever, paratyphoid fever)Foodborne illnessZoonotic disease
05

Safety considerations

Emerging and increasing antibiotic resistance, especially in typhoidal Salmonella (e.g., XDR strains)[2][4]Carriage and zoonotic transmissionDifficult eradication in biofilm or chronic carrier states[4]
06

Interacting drugs

Antibiotics (such as fluoroquinolones, azithromycin, ceftriaxone, ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole)

1 more in the full profile.

07

Biomarkers

O, H, and Vi antigens for serotyping[3][8]Bacterial DNA/RNA detection for diagnosis

Beyond the preview

Go deeper on Salmonella species.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella species.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call